- About Us
- News & Events
Patrick Soon-Shiong, M.D., is a South African born, Chinese-American physician, surgeon, scientist and inventor, who has pioneered revolutionary new treatments for diabetes and cancer. He is a named inventor on more than 50 patents and the author of more than 100 scientific papers. He developed the first encapsulated islet cell transplantation treatment for diabetes and the first nanoparticle albumin-bound, FDA-approved oncology drug.
He is the founder and former chief executive officer of two NASDAQ-listed, multi-billion dollar pharmaceutical companies. Dr. Soon-Shiong recently announced the acquisition of ConjuChem LLC, a company which is developing next generation drugs for diabetes and other diseases, also incorporating albumin. He heads the non-profit Chan Soon-Shiong Institute for Advanced Health (CSS Institute), which announced in July 2011 it had taken over responsibility for National LambdaRail, a non-profit high performance, 12,000 mile, fiber optic communications network linking leading research institutions throughout the United States to support big science projects. The CSS Institute is in the process of connecting medical research centers, sequencing centers and hospitals to this national network, to create a national health information infrastructure.
Dr. Soon-Shiong was awarded the National Library of Medicine's 2010 Distinguished Medical Science Award. Also in 2010, Dr. Soon-Shiong and his wife, Michele B. Chan, were among the first Americans to join with Warren Buffett and Bill Gates in taking the Giving Pledge.
Vasu Rangadass founded Net.Orange™ with one goal in mind -- to improve patient care by simplifying healthcare technology.
Prior to Net.Orange, Vasu was the first employee of i2 Technologies (NASDAQ:ITWO), which later grew to be a global company that revolutionized the supply chain market through innovative approaches based on the principles of Six-Sigma, operations research, and process optimization.
Holding several patents in "Master Data Management" (MDM), Enterprise Software, and Workflow Management (as well as extensive process experience in the Automotive, High-Tech, Consumer Packaged Goods and Retail industries), Vasu has extraordinary proven experience in large-scale enterprise transformation.
The Healthcare industry is currently undergoing similar industry-wide transformation initiatives such as: standardization of EMR, clinical trial management systems, and the need to improve operational and clinical efficiency.
As CEO of Net.Orange, Vasu is now leveraging his past leadership and experience to build an innovative healthcare framework (cOS™ - Clinical Operating System™) that results in superior performance for providers and revolutionizes the way healthcare IT systems are architected in the future.
Vasu is a graduate of India's Osmania University with a Bachelor of Engineering in Electronics and Communications. He holds a MS degree in Computer Science from Texas A & M University, and a PhD in Computer Engineering from University of Texas, Arlington.